CMSC: First Capital (01768) "strongly recommended" rating, expecting market share to increase.
The industry believes that the efficiency of the bulk snack channel is significantly ahead, and it is expected that the company will continue to increase market penetration and maintain a rapid pace of opening new stores.
CMSC released a research report, stating that it first gave a "strongly recommended" rating to (01768), with the company's adjusted net profit expected to reach 2.52 billion, 3.39 billion, and 4.37 billion RMB in 2025, 2026, and 2027 respectively.
The bank pointed out that as the domestic leading bulk snack retailer, the company owns two major brands, including Snack Very busy and Zhao Yiming Snack. As of November 30, 2025, the company has approximately 21,000 stores, with GMV, revenue, and adjusted net profit in the first three quarters of last year reaching 66.1 billion, 46.4 billion, and 1.81 billion RMB, representing a growth of 73%, 75%, and 241%.
The bank believes that the efficiency of the bulk snack channel is significantly ahead, and expects the company to continue to increase its penetration rate and maintain a rapid pace of store opening. Currently, the industry share is accelerating towards the leading companies, with the company having a high-quality team and leading in various aspects such as supply chain, warehousing, distribution, expansion, and branding. It is expected that the strong will become stronger under the industry scale effect, and the company's market share will further increase, releasing profits gradually.
Related Articles

On January 29th, SHOUGANG C-NEW (00103) spent HK$90,200 to repurchase 30,000 shares.

Shoucheng (00697) spent 10.3017 million Hong Kong dollars on January 29th to repurchase 5 million shares.

FUDANZHANGJIANG (01349): Powder for oral solution of amphotericin B butyrate hydrochloride in visualizing brain glioma surgery has obtained a drug market application acceptance letter.
On January 29th, SHOUGANG C-NEW (00103) spent HK$90,200 to repurchase 30,000 shares.

Shoucheng (00697) spent 10.3017 million Hong Kong dollars on January 29th to repurchase 5 million shares.

FUDANZHANGJIANG (01349): Powder for oral solution of amphotericin B butyrate hydrochloride in visualizing brain glioma surgery has obtained a drug market application acceptance letter.

RECOMMEND

Late‑Night Broad Rally As Chip Sector Receives Major Boost: Price Hikes Announced
29/01/2026

Embodied Intelligence: From Frenzy To Breakthrough Through Real‑World Deployment
29/01/2026

Dollar Falls To Four‑Year Low, Trump “Adds Fuel To The Fire”: Not Worried, Dollar Performing Well, Will Find A Reasonable Level
29/01/2026


